Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tetra Bio Pharma Inc TBPMQ

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.


GREY:TBPMQ - Post by User

Comment by Golddetectoron Nov 04, 2021 10:52am
110 Views
Post# 34086661

RE:Bottom

RE:Bottom So are we there? The results already late. Reduvo din due also. This week? Next week? No one knows for but we are very close to a positive results. That all we know. Guys there is a lot of interest in the stock. Everyone is trying to pickup the right entry point. Is bottomed is it not? Sp is stupid cheap currently and low volume is keeping it where it is. We have seen what happens if volume picks up on nr date. Just look up the chart at the start of the trial. Sp was twice. Now we are marching to the end with positive indicators. Now we have a major event like Reduvo din and QIXLEEF interim you can only imagine where that will take us. QIXLEEF is going to be win big if you do not believe that do not buy. If I have a doubt the drug will fail I would have sold my position. This is going to be opioid alternative and will have a big price tag on it. Not my words check latest nr from tetra. " firmly believe it is alternative to opioid" with patients completed trials!! Load at slow days on low volumes go slowly. Once results published everyone will be chasing.

<< Previous
Bullboard Posts
Next >>